The estimated glomerular filtration rate translates creatinine into a measure of kidney function adjusted for age and sex, and is the figure on which chronic kidney disease is classified and many drug doses are adjusted.
The estimated glomerular filtration rate translates creatinine into a measure of kidney function adjusted for age and sex, and is the figure on which chronic kidney disease is classified and many drug doses are adjusted. It is calculated with equations, the 2021 CKD-EPI being the one currently recommended (see the CKD-EPI calculator).
Next: Creatinine · BUN and urea · Potassium
Very high values appear in the early phases of diabetes and in pregnancy. They are not protective: sustained hyperfiltration damages the glomerulus in the long term.
Filtration above 60 mL/min. They are considered kidney disease only if there is also demonstrated damage, such as albuminuria or imaging abnormalities.
Between 30 and 59 mL/min. It is the point at which complications appear and at which the doses of drugs eliminated by the kidney need to be reviewed systematically.
Between 15 and 29 mL/min. Severe kidney disease, with preparation of the kidney replacement strategy.
Below 15 mL/min. Kidney failure, with an indication for dialysis or transplant depending on the clinical context.
The full classification combines filtration with albuminuria (see the KDIGO classification): two people with the same filtration have very different prognoses depending on whether or not they excrete albumin in the urine. The speed of decline between tests is also assessed.
The 2021 CKD-EPI, which estimates filtration from creatinine, age and sex. It is the version that no longer includes the race adjustment present in earlier formulations.
Systematic review of doses becomes especially necessary from stage G3, that is, below 60 mL/min/1.73 m², which is also where the complications of chronic kidney disease begin to appear.
This page is educational material for medical training: it describes the clinical meaning of the test and the causes of its abnormalities. It is not a diagnosis or a treatment recommendation, and it does not replace the laboratory report or the individual clinical assessment, which interprets each result in its context.